MG: Supervision, Writing review & editing
Clinical efficacy of estradiol transdermal system in the treatment of hot flashes in postmenopausal women
Retatrutide needs additional TRIUMPH trial results throughout 2026 before submitting for FDA approval in late 2026 or early 2027, with approval expected in late 2027 and launch in early 2028
And as I always say, anytime you want to answer a question about kind of why something evolved to be a particular way, you have to remember that neither I nor anyone else was involved in the design phase
What if I don't want a lifelong injection
Martinelli-Klay CP, Laporte ML, Martinelli CR, Martinelli C, Lombardi T